How Novartis is embracing the digital and data revolution

"Embracing digital and data is a top priority for Novartis, chief medical officer John Tsai told journalists on a media tour at the company’s campus in Basel this week. But according to Ronenn Roubenoff, global head, translational medicine discovery & profiling, and musculoskeletal translational medicine, at Novartis, the pharma industry has not been at the frontline of this revolution, taking advantage of the opportunities that it brings. ..." Lire la suite